Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

High-dose chemotherapy in germ-cell cancer salvage regimens: where next?

Nature Clinical Practice Urology volume 2, pages 590–591 (2005)Cite this article

boxed-textPico JL et al. (2005) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16: 1152–1159

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Loehrer PJ Sr et al. (1998) Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumour. J Clin Oncol 16: 2500–2504

    Article  CAS  Google Scholar 

  2. Bhardwa JM et al. (2005) Assessing the size and stage of testicular germ cell tumours: 1984–2003. BJU Int 96: 819–821

    Article  Google Scholar 

  3. Mead GM et al. (2005) A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. Br J Cancer 93: 178–184

    Article  CAS  Google Scholar 

  4. Shamash J et al. (1999) Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy. Ann Oncol 10: 685–692

    Article  CAS  Google Scholar 

  5. Shamash J et al. (2005) A phase II study of irinotecan, paclitaxel and oxaliplatin (IPO) in patients with multiply relapsed germ cell tumours (GCT) [abstract]. J Clin Oncol 23 (Suppl): 4527

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor at the London School of Medicine and Sir Maxwell Joseph Professor in Oncology in the Department of Medical Oncology at St Bart's, London, UK

    R Tim D Oliver

Authors
  1. R Tim D Oliver
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Tim D Oliver.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oliver, R. High-dose chemotherapy in germ-cell cancer salvage regimens: where next?. Nat Rev Urol 2, 590–591 (2005). https://doi.org/10.1038/ncpuro0358

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0358

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing